Comparing Arcalyst vs Kineret
| Arcalyst | Kineret |
|
|---|
| Arcalyst (rilonacept) | Kineret (anakinra) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Pericarditis, Cryopyrin-Associated Periodic Syndromes, Interleukin-1 Receptor Antagonist Deficiency, Muckle Wells Syndrome, Familial Cold Autoinflammatory Syndrome. Arcalyst may also... View more |
Prescription only
Prescribed for Interleukin-1 Receptor Antagonist Deficiency, Rheumatoid Arthritis, Cryopyrin-Associated Periodic Syndromes, COVID-19. Kineret may also be used for purposes not listed in this medication guide. View more |
Related suggestions Cryopyrin-Associated Periodic Syndromes
Interleukin-1 Receptor Antagonist Deficiency
|
|||||||||||||||
| More about Arcalyst (rilonacept) | More about Kineret (anakinra) | ||||||||||||||||
| Generic Status | |||||||||||||||||
|
No lower-cost generic available |
No lower-cost generic available |
||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Arcalyst has an average rating of 10.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Kineret has an average rating of 8.8 out of 10 from a total of 5 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Side Effects | |||||||||||||||||
|
Common side effects include:
See also: Arcalyst side effects in more detail. |
Common side effects include:
See also: Kineret side effects in more detail. |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Arcalyst prices |
View all Kineret prices |
||||||||||||||||
| Dosage Form(s) Available | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
|
N/A |
6 hours |
||||||||||||||||
| CSA Schedule ** View glossary of terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 384 drugs are known to interact with Arcalyst:
|
A total of 385 drugs are known to interact with Kineret:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
February 27, 2008 |
November 14, 2001 |
||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient resources | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.